Dina Burkitbayeva

CEO & Co-Founder, Freedom Biosciences

Alumni Council

Dina Burkitbayeva is the CEO and Co-Founder of Freedom Biosciences, a Yale spinout and clinical stage biotech company developing next generation ketamine and psychedelic therapeutics. Dina Burkitbayeva is also the Co-Founder and former general partner at PsyMed Ventures, a venture fund focused on cutting edge mental health treatments including psychedelic therapeutics, neurotechnology and precision psychiatry. Dina holds an MBA from Harvard Business School and lives in the San Francisco Bay Area.